1 Executive Summary
2 Scope Of The Report
2.1 Market Definition 13
2.2 Scope Of The Study 13
2.2.1 Research Objectives 13
2.2.2 Assumptions 13
2.2.3 Limitations 13
2.3 Market Structure 14
3 Research Methodology
3.1 Research Process 16
3.2 Primary Research 16
3.3 Secondary Research 16
3.4 Market Size Estimation 17
3.5 Forecast Model 17
4 Market Dynamics
4.1 Introduction 19
4.2 Drivers 20
4.2.1 Drivers Advancement In Human Body Modifications 20
4.2.2 Growing Usage Of Exoskeletons In Military Applications 21
4.2.3 Increased Human And Machinery Safety 22
4.3 Challenges 23
4.3.1 Social And Ethical Issues Pertaining Non-Medical Augmentation 23
4.3.2 High Cost Of Medical Implants And Lack Of Skilled Professionals 23
4.4 Market Trends 24
4.4.1 Growth Trends 24
4.4.1.1 Exoskeletons 24
4.4.1.2 Real Time Language Translation 24
4.4.1.3 Augmented Vision 24
5 Market Factor Analysis
5.1 Porter’s Five Force Analysis 26
5.1.1 Threat Of New Entrants 26
5.1.2 Threat Of Rivalry 26
5.1.3 Threat Of Substitute 27
5.1.4 Bargaining Power Of Supplier 27
5.1.5 Bargaining Power Of Buyer 27
6 Global Human Augmentation Market, By Product
6.1 Introduction 29
6.1.1 Wearable Augmentation 30
6.1.2 In-Built Augmentation 30
7 Global Human Augmentation Market: By End-User
7.1 Introduction 32
7.1.1 Healthcare 33
7.1.2 Defense 33
7.1.3 Manufacturing 33
7.1.4 IT 34
7.1.5 Others 34
8 Global Human Augmentation Market, By Region
8.1 Introduction 36
8.2 North America 38
8.2.1 U.S. 41
8.2.2 Canada 41
8.2.3 Mexico 42
8.3 Europe 43
8.3.1 The U.K 46
8.3.2 Germany 47
8.3.3 France 48
8.3.4 Spain 49
8.3.5 Italy 50
8.3.6 Rest Of Europe 51
8.4 Asia Pacific 52
8.4.1 China 55
8.4.2 Jaan 56
8.4.3 India 57
8.4.4 Rest Of Asia Pacific 58
8.5 Rest Of The World 59
9 Company Profiles
9.1 Market Evolution 63
9.2 B-Temia, Inc. 64
9.2.1 Company Overview 64
9.2.2 Financials 64
9.2.3 Products 64
9.2.4 Strategy 64
9.2.5 Key Developments 64
9.3 BrainGate Company 65
9.3.1 Company Overview 65
9.3.2 Financials 65
9.3.3 Products 65
9.3.4 Strategy 65
9.3.5 Key Developments 65
9.4 Ekso Bionics Holdings, Inc. 66
9.4.1 Company Overview 66
9.4.2 Financials 66
9.4.3 Products 66
9.4.4 Strategy 66
9.4.5 Key Developments 66
9.5 Cyber Dyne, Inc. 67
9.5.1 Company Overview 67
9.5.2 Financials 67
9.5.3 Products 67
9.5.4 Strategy 67
9.5.5 Key Developments 67
9.6 Raytheon Company 68
9.6.1 Company Overview 68
9.6.2 Financials 68
9.6.3 Products 68
9.6.4 Strategy 68
9.6.5 Key Developments 68
9.7 Samsung Electronics Co Ltd 69
9.7.1 Company Overview 69
9.7.2 Financials 69
9.7.3 Products 69
9.7.4 Strategy 69
9.7.5 Key Developments 69
9.8 Bionik Laboratories Corp 70
9.8.1 Company Overview 70
9.8.2 Financials 70
9.8.3 Products 70
9.8.4 Strategy 70
9.8.5 Key Developments 70
9.9 Toyota Motor Corporation 71
9.9.1 Company Overview 71
9.9.2 Financials 71
9.9.3 Products 71
9.9.4 Strategy 71
9.9.5 Key Developments 71
9.10 Panasonic Corporation 72
9.10.1 Company Overview 72
9.10.2 Financials 72
9.10.3 Products 72
9.10.4 Strategy 72
9.10.5 Key Developments 72
9.11 Parker Hannifin 73
9.11.1 Company Overview 73
9.11.2 Financials 73
9.11.3 Products 73
9.11.4 Strategy 73
9.11.5 Key Developments 73
10 List Of Tables
TABLE 1 GLOBAL HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 29
TABLE 2 GLOBAL HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 32
TABLE 3 GLOBAL HUMAN AUGMENTATION MARKET, BY REGION, 2020-2027 (USD MIL-LION) 36
TABLE 4 NORTH AMERICA HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 39
TABLE 5 NORTH AMERICA HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 40
TABLE 6 NORTH AMERICA HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 40
TABLE 7 U.S. HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 41
TABLE 8 U.S. HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 41
TABLE 9 CANADA HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 41
TABLE 10 CANADA HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 42
TABLE 11 MEXICO HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 42
TABLE 12 MEXICO HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 42
TABLE 13 EUROPE HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MIL-LION) 44
TABLE 14 EUROPE HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 45
TABLE 15 EUROPE HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 45
TABLE 16 U.K HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 46
TABLE 17 U.K HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 46
TABLE 18 GERMANY HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 47
TABLE 19 GERMANY HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 47
TABLE 20 FRANCE HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 48
TABLE 21 FRANCE HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 48
TABLE 22 SPAIN HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 49
TABLE 23 SPAIN HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 49
TABLE 24 ITALY HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 50
TABLE 25 ITALY HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 50
TABLE 26 REST OF EUROPE HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 51
TABLE 27 REST OF EUROPE HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 51
TABLE 28 ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 53
TABLE 29 ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 54
TABLE 30 ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 54
TABLE 31 CHINA HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 55
TABLE 32 CHINA HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 55
TABLE 33 JAPAN HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 56
TABLE 34 JAPAN HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 56
TABLE 35 INDIA HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 57
TABLE 36 INDIA HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MIL-LION) 57
TABLE 37 REST OF ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 58
TABLE 38 REST OF ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 58
TABLE 39 REST OF THE WORLD HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 60
TABLE 40 REST OF THE WORLD HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 61
TABLE 41 REST OF THE WORLD HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 61
11 List Of Figures
FIGURE 1 TOP DOWN & BOTTOMUP APPROACH 17
FIGURE 2 FORECAST MODEL 17
FIGURE 3 PORTER’S FIVE FORCES ANALYSIS OF GLOBAL HUMAN AUGMENTATION MAR-KET 26
FIGURE 4 GLOBAL HUMAN AUGMENTATION MARKET, BY PRODUCT, 2020-2027 (USD MIL-LION) 29
FIGURE 5 GLOBAL HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 32
FIGURE 6 GLOBAL HUMAN AUGMENTATION MARKET, BY REGION, 2020-2027 (USD MIL-LION) 36
FIGURE 7 GLOBAL HUMAN AUGMENTATION MARKET, BY REGION: IMPACT ANALYSIS 37
FIGURE 8 GLOBAL HUMAN AUGMENTATION MARKET: MARKET SIZE AND MARKET POTEN-TIAL IN MAJOR COUNTRIES (USD MILLION) 37
FIGURE 9 NORTH AMERICA HUMAN AUGMENTATION MARKET, BY COUNTRIES, 2020-2027 (USD MILLION) 39
FIGURE 10 NORTH AMERICA HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 40
FIGURE 11 EUROPE HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MIL-LION) 44
FIGURE 12 EUROPE HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 45
FIGURE 13 ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 53
FIGURE 14 ASIA PACIFIC HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 54
FIGURE 15 REST OF THE WORLD HUMAN AUGMENTATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 60
FIGURE 16 REST OF THE WORLD HUMAN AUGMENTATION MARKET, BY END USER, 2020-2027 (USD MILLION) 61